Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
N. Barnes.
Relative safety and efficacy of inhaled corticosteroids.
J Allergy Clin Immunol, 101 (1998), pp. 460-464
[2.]
D.J. Clarck, R.A. Clarck, B.J. Lipworth.
Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Thorax, 51 (1996), pp. 941-943
[3.]
B.J. Lipworth, D.J. Clarck, L.A. McFarlane.
Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Thorax, 52 (1997), pp. 686-689
[4.]
O.D. Wolthers, S. Pedersen.
Measures of systemic activity of inhaled glucocorticoid in children: a comparison of urine cortisol excretion and knemometry.
Respir Med, 89 (1995), pp. 347-349
[5.]
A. Hoffmann-Streb, D. L'Allemand, B. Niggemann, P. Buttner, U. Wahn.
Adrenal cortex function in children with bronchial asthma in fluticasone therapy.
Monats Kinderh, 141 (1993), pp. 508-512
[6.]
P.K. Yiallouros, A.D. Milner, E. Conway, J.W. Honour.
Adrenal function and high dose inhaled corticosteroids for asthma.
Arch Dis Child, 76 (1997), pp. 405-410
[7.]
D.B. Peden, W.E. Berger, M.J. Noonan, M.R. Thomas, V.L. Hendricks, A.G. Hamedani.
Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
J Allergy Clin Immunol, 102 (1998), pp. 32-38
[8.]
C.A. MacKenzie, E.G. Weinberg, E. Tabachnik, M. Taylor, J. Havnen, K. Crescenzi.
A placebo controlled trial of fluticasone propionate in asthmatic children.
Eur J Pediatr, 152 (1993), pp. 856-860
[9.]
J.C. Barnes, C. Hallett, T.A.J. Harris.
Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclometasone dipropionate at half the micrograme dose or less.
Respir Med, 92 (1998), pp. 95-104
[10.]
J.C. Hoekx, G. Hedlin, W. Pedersen, R. Sorva, K. Hollingworth, J. Efthimiou.
Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 mcg/day.
Eur Respir J, 9 (1996), pp. 2263-2272
[11.]
L. Agertoft, S. Pedersen.
A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler (clinical aspects of allergic disease).
J Allergy Clin Immunol, 99 (1997), pp. 773-780
[12.]
P. Gustafsson, J. Tsanakas, M. Gold, R. Primhak, M. Radford, E. Gillies.
Comparison of the efficacy and safety of inhaled fluticasone propionate 200 microg/day with inhaled beclomethasone dipropionate 400 microg/day in mild and moderate asthma.
Arch Dis Child, 69 (1993), pp. 206-211
[13.]
D.B. Allen, E.A. Bronsky, C.F. LaForce, R.A. Nathan, D.G. Tinkelman, M.L. Vandewalker.
Growth in asthmatic children treated with fluticasone propionate.
J Pediatr, 132 (1998), pp. 472-477
[14.]
S.M. Holliday, D. Faulds, E.M. Sorkin.
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.
Drugs, 47 (1994), pp. 318-331
[15.]
A.C. Ferguson, S. Spier, A. Manjra, F.G. Versteegh, S. Mark, P. Zhang.
Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
J Pediatr, 134 (1999), pp. 422-427
[16.]
L. Agertoft, S. Pedersen.
Bone, growth and collagen markers in children treated with fluticasone propionate and budesonide [resumen].
Eur Respir J, 9 (1996), pp. 295
[17.]
B. Zimmerman, M. Gold, D. Wherrett, A.K. Hanna.
Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate.
J Allergy Clin Immunol, 101 (1998), pp. 425-426
[18.]
G. Todd, K. Dunlop, J. McNaboe, M.F. Ryan, D. Carson, M.D. Shields.
Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
Lancet, 348 (1966), pp. 27-29
[19.]
P.C. Ng, T.F. Fok, G.W. Wong, C.W. Lam, C.H. Lee, M.Y. Wong.
Pituitary adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment.
J Clin Endocrinol Metab, 83 (1998), pp. 2390-2393
[20.]
W.W. Storms.
Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis.
J Asthma, 35 (1998), pp. 313-336
[21.]
L. Thorsson, K. Dahlstroom, S. Edsbacker, A. Kallen, J. Paulson, J.E. Wiren.
Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
Br J Clin Pharmacol, 43 (1997), pp. 155-161
Copyright © 2000. Asociación Española de Pediatría
